← Back to Search

Combined gastric mucosal ablation with endoscopic sleeve gastroplasty for Obesity

N/A
Recruiting
Research Sponsored by True You Weight Loss
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months, 6 months, 9 months, 12 months, 15 months, 24 months
Awards & highlights
No Placebo-Only Group

Summary

The purpose of this study is to construct a multi-site, prospective registry to evaluate the clinical outcomes of patients who have undergone combined gastric mucosal ablation with endoscopic sleeve gastroplasty at True You Weight Loss.

Eligible Conditions
  • Obesity

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months, 6 months, 9 months, 12 months, 15 months, 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months, 6 months, 9 months, 12 months, 15 months, 24 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Change in Body Mass Index (BMI) from Baseline
Percent Change in Total Body Weight Loss (TBWL) from Baseline
Percent Excess Weight Loss from Baseline (EWL)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Combined gastric mucosal ablation with endoscopic sleeve gastroplastyExperimental Treatment1 Intervention
All patients included in the multi-site, prospective registry will undergo the combined gastric mucosal ablation with endoscopic sleeve gastroplasty procedure, regardless of their participation in the research study.

Find a Location

Who is running the clinical trial?

True You Weight LossLead Sponsor
4 Previous Clinical Trials
268 Total Patients Enrolled
4 Trials studying Obesity
268 Patients Enrolled for Obesity
~67 spots leftby Jan 2028